A medical technology company providing organ transport systems.
AI-generated insights about TransMedics Group Inc. from various financial sources
Has a compelling long-term growth story with guidance to triple the business by 2028 and is a potential acquisition target. The speaker is waiting for a post-earnings dip to add to their position.
Has a compelling long-term growth story with guidance to triple the business by 2028 and is a potential acquisition target. The speaker is waiting for a post-earnings dip to add to their position.